Seattle biotech company Kineta completes merger, begins trading on Nasdaq - Seattle biotech company Kineta completed its merger with Yumanity Therapeutics, a ... - https://www.geekwire.com/2022/seattle-biotech-company-kineta-completes-merger-begins-trading-on-nasdaq/ #health/lifesciences #kineta

Vista antibody is on a fast track to be developed as a checkpoint blockade agent by #kineta #kinetapharma in cancer. Very nice data showing reversal of negative immune signals similar to #PD1 Peomoter is responsive to hypoxia. Protein activated in low pH #immunotherapy #ASH22 #checkpoint